Short description:
Immunes system mapping with AI
Drug notes:
Contact us to add description: recruit@workinbiotech.com
Long description:
Immunai is developing AI-powered solutions to revolutionize the discovery and development of immunotherapies. The company's platform integrates single-cell multiomics, machine learning, and big data computing to map the immune system at scale. Immunai's insights are used to identify and validate novel therapeutic targets and to develop new immunotherapies that are more effective and less toxic than existing treatments. Immunai's pipeline includes programs in a variety of therapeutic areas, including cancer, infectious diseases, and autoimmune diseases. The company's lead product candidate, IMI-101, is a small molecule inhibitor of a key checkpoint molecule that is involved in the suppression of the immune system. IMI-101 is currently in Phase 1 clinical trials for the treatment of advanced solid tumors.
Jobs:
Associate Scientist, Molecular Profiling New York, NY|25 days ago
Systems Immunologist (Scientist II) New York City Metropolitan Area|30 days ago
Laboratory Operations Technician New York, US|37 days ago
Computational Biologist (Data Curation) Prague, Prague, Czechia|100+ days ago
Scientist II, Systems Immunology New York, US|100+ days ago
Director of Business Development New York, US|100+ days ago